BRPI0813662A2 - Composição vacinal, processos para a obtenção da forma sanitária da composição vacinal e para a obtenção da composição vacinal, e, uso da composição vacinal - Google Patents

Composição vacinal, processos para a obtenção da forma sanitária da composição vacinal e para a obtenção da composição vacinal, e, uso da composição vacinal

Info

Publication number
BRPI0813662A2
BRPI0813662A2 BRPI0813662-9A2A BRPI0813662A BRPI0813662A2 BR PI0813662 A2 BRPI0813662 A2 BR PI0813662A2 BR PI0813662 A BRPI0813662 A BR PI0813662A BR PI0813662 A2 BRPI0813662 A2 BR PI0813662A2
Authority
BR
Brazil
Prior art keywords
vacinal
composition
obtaining
vacinal composition
procedures
Prior art date
Application number
BRPI0813662-9A2A
Other languages
English (en)
Inventor
Gryssell Maria Rodriguez Martinez
Lisel Vina Rodriguez
Loany Calvo Gonzalez
Ariadna Cuevas Fiallo
Ernesto Chico Veliz
Tania Crombet Ramos
Airama Albisa Novo
Gisela Maria Gonzales Marinello
Agustin Bienvenido Lage Davila
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40225717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0813662(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of BRPI0813662A2 publication Critical patent/BRPI0813662A2/pt
Publication of BRPI0813662B1 publication Critical patent/BRPI0813662B1/pt
Publication of BRPI0813662B8 publication Critical patent/BRPI0813662B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00113—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BRPI0813662A 2007-06-29 2008-06-26 composição vacinal, processo para a obtenção de uma composição vacinal, e, uso de uma composição vacinal BRPI0813662B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU20070154A CU23652A1 (es) 2007-06-29 2007-06-29 Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención
CUCU154-2007 2007-06-29
PCT/CU2008/000005 WO2009003425A1 (es) 2007-06-29 2008-06-26 Obtención de un preparado vacunal homogéneo para el tratamiento del cáncer

Publications (3)

Publication Number Publication Date
BRPI0813662A2 true BRPI0813662A2 (pt) 2014-12-30
BRPI0813662B1 BRPI0813662B1 (pt) 2019-05-14
BRPI0813662B8 BRPI0813662B8 (pt) 2021-05-25

Family

ID=40225717

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813662A BRPI0813662B8 (pt) 2007-06-29 2008-06-26 composição vacinal, processo para a obtenção de uma composição vacinal, e, uso de uma composição vacinal

Country Status (30)

Country Link
US (2) US8778879B2 (pt)
EP (1) EP2184072B1 (pt)
JP (1) JP5368437B2 (pt)
KR (1) KR20100039372A (pt)
CN (1) CN101790383B (pt)
AR (1) AR067085A1 (pt)
AT (1) ATE536885T1 (pt)
AU (1) AU2008271798B2 (pt)
BR (1) BRPI0813662B8 (pt)
CA (1) CA2692340C (pt)
CL (1) CL2008001936A1 (pt)
CO (1) CO6251274A2 (pt)
CU (1) CU23652A1 (pt)
CY (1) CY1112476T1 (pt)
DK (1) DK2184072T3 (pt)
EA (1) EA021905B1 (pt)
ES (1) ES2379130T3 (pt)
HR (1) HRP20120218T1 (pt)
JO (1) JO2777B1 (pt)
MY (1) MY149136A (pt)
NZ (1) NZ582829A (pt)
PE (2) PE20131037A1 (pt)
PL (1) PL2184072T3 (pt)
PT (1) PT2184072E (pt)
RS (1) RS52196B (pt)
SI (1) SI2184072T1 (pt)
TW (1) TWI409080B (pt)
UY (1) UY31184A1 (pt)
WO (1) WO2009003425A1 (pt)
ZA (1) ZA201000609B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20200032A7 (es) * 2020-06-09 2022-01-13 Ct Inmunologia Molecular Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer
CN114594257B (zh) * 2022-05-09 2022-08-05 北京生物制品研究所有限责任公司 含CpG ODN的吸附型疫苗的解吸附组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
EP0657175B1 (en) 1993-12-09 2005-03-02 Centro de Inmunologia Molecular Vaccine comprising human autologous epidermal growth factor and use thereof
CU23077A1 (es) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
CU22979A1 (es) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina
CU22999A1 (es) * 2001-12-04 2004-10-12 Centro Inmunologia Molecular Método de tratamiento de enfermedades malignas e infecciosas crónicas
GB0109297D0 (en) * 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines

Also Published As

Publication number Publication date
SI2184072T1 (sl) 2012-04-30
KR20100039372A (ko) 2010-04-15
US8841251B2 (en) 2014-09-23
CN101790383B (zh) 2013-05-29
ES2379130T3 (es) 2012-04-23
MY149136A (en) 2013-07-15
US20100196412A1 (en) 2010-08-05
ZA201000609B (en) 2010-10-27
TW200918092A (en) 2009-05-01
RS52196B (sr) 2012-10-31
WO2009003425A1 (es) 2009-01-08
DK2184072T3 (da) 2012-04-02
CA2692340C (en) 2015-11-17
AU2008271798B2 (en) 2012-06-07
JO2777B1 (en) 2014-03-15
PT2184072E (pt) 2012-03-21
AU2008271798A1 (en) 2009-01-08
HK1145979A1 (en) 2011-05-13
TWI409080B (zh) 2013-09-21
JP5368437B2 (ja) 2013-12-18
EA021905B1 (ru) 2015-09-30
CA2692340A1 (en) 2009-01-08
NZ582829A (en) 2012-03-30
EA201070080A1 (ru) 2010-12-30
HRP20120218T1 (hr) 2012-04-30
CL2008001936A1 (es) 2009-09-25
JP2010531817A (ja) 2010-09-30
PL2184072T3 (pl) 2012-05-31
CO6251274A2 (es) 2011-02-21
PE20131037A1 (es) 2013-10-07
US8778879B2 (en) 2014-07-15
CN101790383A (zh) 2010-07-28
EP2184072B1 (en) 2011-12-14
US20130039940A1 (en) 2013-02-14
BRPI0813662B8 (pt) 2021-05-25
BRPI0813662B1 (pt) 2019-05-14
EP2184072A1 (en) 2010-05-12
CY1112476T1 (el) 2015-12-09
CU23652A1 (es) 2011-05-27
PE20090426A1 (es) 2009-05-05
AR067085A1 (es) 2009-09-30
ATE536885T1 (de) 2011-12-15
UY31184A1 (es) 2009-01-05
EP2184072A4 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0821668A2 (pt) Uso
BRPI0807453A2 (pt) Preparação sólida
BRPI1014700A2 (pt) composição de revestimento e método para a fabricação e uso da mesma.
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0821316A2 (pt) Adaptador antioclusão para cateter
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0810557A2 (pt) composição
DK2125048T3 (da) Præparat
BRPI0811274A2 (pt) Composição
EP2189118A4 (en) ULTRASOUND DEVICE
PT2209464E (pt) Composição farmacêutica antimalárica
PT2182988E (pt) Composição radiofarmacêutica
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0820960A2 (pt) composição
BRPI0812961A2 (pt) estrutura para acondicionamento
FI20075086A0 (fi) Aromikoostumus
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina
EP2119430A4 (en) PERLENDE COMPOSITION
EP2188349A4 (en) OXYGEN ABSORBING COMPOSITION

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF